These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8888087)

  • 1. Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics.
    Klamerus KJ; Parker VD; Rudolph RL; Derivan AT; Chiang ST
    Pharmacotherapy; 1996; 16(5):915-23. PubMed ID: 8888087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of venlafaxine extended release 75  mg and desvenlafaxine 50  mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
    Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
    Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithium.
    Troy SM; Parker VD; Hicks DR; Boudino FD; Chiang ST
    J Clin Pharmacol; 1996 Feb; 36(2):175-81. PubMed ID: 8852394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite.
    Klamerus KJ; Maloney K; Rudolph RL; Sisenwine SF; Jusko WJ; Chiang ST
    J Clin Pharmacol; 1992 Aug; 32(8):716-24. PubMed ID: 1487561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
    Troy SM; Parker VD; Fruncillo RJ; Chiang ST
    J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
    ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
    J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes--focus on venlafaxine and O-desmethylvenlafaxine.
    Kandasamy M; Srinivas P; Subramaniam K; Ravi S; John J; Shekar R; Srinivas N; Thangam S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):879-87. PubMed ID: 20446083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine.
    Lindh JD; Annas A; Meurling L; Dahl ML; AL-Shurbaji A
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):401-6. PubMed ID: 12898080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
    Lessard E; Yessine MA; Hamelin BA; O'Hara G; LeBlanc J; Turgeon J
    Pharmacogenetics; 1999 Aug; 9(4):435-43. PubMed ID: 10780263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of a pharmacokinetic drug-drug interaction with venlafaxine extended-release/indinavir and desvenlafaxine extended-release/indinavir.
    Jann MW; Spratlin V; Momary K; Zhang H; Turner D; Penzak SR; Wright A; VanDenBerg C
    Eur J Clin Pharmacol; 2012 May; 68(5):715-21. PubMed ID: 22173281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
    Jiang F; Kim HD; Na HS; Lee SY; Seo DW; Choi JY; Ha JH; Shin HJ; Kim YH; Chung MW
    Psychopharmacology (Berl); 2015 Jun; 232(11):1899-909. PubMed ID: 25510856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a first-pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects.
    Taft DR; Iyer GR; Behar L; DiGregorio RV
    Drug Metab Dispos; 1997 Oct; 25(10):1215-8. PubMed ID: 9321527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of renal disease on the disposition of venlafaxine.
    Troy SM; Schultz RW; Parker VD; Chiang ST; Blum RA
    Clin Pharmacol Ther; 1994 Jul; 56(1):14-21. PubMed ID: 8033490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of venlafaxine and O-desmethylvenlafaxine in laboratory animals.
    Howell SR; Hicks DR; Scatina JA; Sisenwine SF
    Xenobiotica; 1994 Apr; 24(4):315-27. PubMed ID: 8059535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
    Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
    Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.
    Lindauer A; Siepmann T; Oertel R; Jung A; Ziemssen T; Jaehde U; Kirch W; Siepmann M
    Clin Pharmacokinet; 2008; 47(11):721-31. PubMed ID: 18840027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxine.
    Troy SM; Rudolph R; Mayersohn M; Chiang ST
    J Clin Pharmacol; 1998 May; 38(5):467-74. PubMed ID: 9602962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine: a heterocyclic antidepressant.
    Ellingrod VL; Perry PJ
    Am J Hosp Pharm; 1994 Dec; 51(24):3033-46. PubMed ID: 7856622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of venlafaxine, O-desmethylvenlafaxine, and O-desmethylvenlafaxine to venlafaxine ratio in postmortem human brain tissue.
    Murrell MD; Cruz DA; Javors MA; Thompson PM
    J Forensic Sci; 2014 May; 59(3):683-9. PubMed ID: 24502274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.